A new carbapenem agent for the control of severe infection caused by the most agressive nosocomial strains in critically ill patients (2016)
- Authors:
- USP affiliated authors: SILVA JUNIOR, CARLINDO VIEIRA DA - FCF ; SANTOS, SILVIA REGINA CAVANI JORGE - FCF
- Unidade: FCF
- Assunto: CONTROLE DE INFECÇÕES
- Language: Inglês
- Imprenta:
- Source:
- Título: Brazilian Journal of Pharmaceutical Sciences
- ISSN: 1984-8250
- Volume/Número/Paginação/Ano: v. 52, suppl. 1, p. 10 res. FCF015, 2016
- Conference titles: Pharmaceutical Sciences and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo
-
ABNT
SOUSA, Ednalva Maria de et al. A new carbapenem agent for the control of severe infection caused by the most agressive nosocomial strains in critically ill patients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 13 fev. 2026. , 2016 -
APA
Sousa, E. M. de, Silva Junior, C. V., Gomez, D. de S., & Santos, S. R. C. J. (2016). A new carbapenem agent for the control of severe infection caused by the most agressive nosocomial strains in critically ill patients. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. -
NLM
Sousa EM de, Silva Junior CV, Gomez D de S, Santos SRCJ. A new carbapenem agent for the control of severe infection caused by the most agressive nosocomial strains in critically ill patients. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 10 res. FCF015.[citado 2026 fev. 13 ] -
Vancouver
Sousa EM de, Silva Junior CV, Gomez D de S, Santos SRCJ. A new carbapenem agent for the control of severe infection caused by the most agressive nosocomial strains in critically ill patients. Brazilian Journal of Pharmaceutical Sciences. 2016 ; 52 10 res. FCF015.[citado 2026 fev. 13 ] - Imipenem pk/pd correlation for the control of pulmonary infection in critical burn patients with sepsis
- Pk/pd correlation for the control of infection by pseudomonas aeruginosa in critical burn patient: report case after electrical accident
- Imipenem serum measurements in real time for target attainment against more agressive strains MlC>2mg/l in septic burns
- Vancomycin prescription changes in real time based on drug plasma monitoring against Staphylococcus spp MlC 2mg/l in critically ill paediatric burns
- Triazoles or echinocandins antifungal therapy against candida glabrata in sepsis?
- PK/PD correlation for carbapenems for the control of nosocomial infection in critical burn pediatric patients
- PK modeling of vancomycin-piperacillin for the control of severe infections in critical burn patients for dose adjustment purpose
- Pharmacokinetic-pharmacodynamic correlation of imipenem in pediatric burn patients using a bioanalytical liquid chromatographic method
- Correlação in vivo-in vitro aplicada no ajuste de dose da vancomicina para o controle das infecções graves em crianças grandes queimadas
- Does the amikacin effectiveness is reached in septic critically ill patient after the empirical daily dose against gram-negative mic 32mg/l strains?
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
